Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor-Reference-Cited by-同舟云学术

Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor

Published:2015-02 Issue:2 Volume:26 Page:348-354
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Won J.K.,Keam B.,Koh J.,Cho H.J.,Jeon Y.K.,Kim T.M.,Lee S.H.,Lee D.S.,Kim D.W.,Chung D.H.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/26/2/348/24065209/mdu530.pdf

Reference26 articles.

1. Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

2. An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting;Goto;Ann Oncol,2012

3. Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer;Kim;Lung Cancer,2012

4. Next-generation sequencing of lung cancer EGFR exons 18–21 allows effective molecular diagnosis of small routine samples (cytology and biopsy);de Biase;PLoS One,2013

5. Predictive efficacy of low burden EGFR mutation detected by next-generation sequencing on response to EGFR tyrosine kinase inhibitors in non-small-cell lung carcinoma;Kim;PLoS One,2013

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in artificial intelligence applications in the field of lung cancer;Frontiers in Oncology;2024-09-06

2. Concomitant epidermal growth factor receptor mutation/c-ros oncogene 1 rearrangement in non-small cell lung cancer: A case report;World Journal of Clinical Oncology;2024-07-24

3. Application of liquid biopsy in lung cancer management;Indian Journal of Pathology and Microbiology;2024-07

4. Analysis of Clinical Features and Treatment Strategies in Advanced Lung Adenocarcinoma Patients With Acquired ALK Fusion After Resistance of EGFR-TKIs;2024-05-31

5. Remarkable response to third-generation EGFR-TKI plus crizotinib in a patient with pulmonary adenocarcinoma harboring EGFR and ROS1 co-mutation: a case report;Frontiers in Oncology;2024-02-27